NeoGenomics Inc (NEO) stock
NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3023% below fair value
$15.25−0.16 (-1.04%)
Close on Nov 17, 2026Market cap $1.97BP/E –Yield –
NeoGenomics gross margin
Gross margin is gross profit as a percentage of revenue.
NeoGenomics's gross margin for the twelve months ending Sep 30, 2026 was 44.8%. For fiscal 2025 it was 43.2%, against 43.9% the year before. The highest annual figure on record is 48.1% in fiscal 2019.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 43.2% | −0.7 |
| FY2024 | Dec 31, 2024 | 43.9% | +2.6 |
| FY2023 | Dec 31, 2023 | 41.3% | +4.5 |
| FY2022 | Dec 31, 2022 | 36.9% | −1.8 |
| FY2021 | Dec 31, 2021 | 38.6% | −3.2 |
| FY2020 | Dec 31, 2020 | 41.8% | −6.3 |
| FY2019 | Dec 31, 2019 | 48.1% | +2.2 |
| FY2018 | Dec 31, 2018 | 46.0% | +3.5 |
| FY2017 | Dec 31, 2017 | 42.4% | +0.1 |
| FY2016 | Dec 31, 2016 | 42.3% | −1.5 |
| FY2015 | Dec 31, 2015 | 43.8% | −2.9 |
| FY2014 | Dec 31, 2014 | 46.8% | −1.0 |
| FY2013 | Dec 31, 2013 | 47.7% | +2.9 |
| FY2012 | Dec 31, 2012 | 44.8% | +0.1 |
| FY2011 | Dec 31, 2011 | 44.7% | −1.2 |
| FY2010 | Dec 31, 2010 | 45.9% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 46.2% | +3.3 |
| Q2 FY2026 | Jun 30, 2026 | 45.6% | +3.0 |
| Q1 FY2026 | Mar 31, 2026 | 43.3% | −0.3 |
| Q4 FY2025 | Dec 31, 2025 | 43.8% | −1.1 |
| Q3 FY2025 | Sep 30, 2025 | 42.8% | −1.8 |
| Q2 FY2025 | Jun 30, 2025 | 42.6% | −1.5 |
| Q1 FY2025 | Mar 31, 2025 | 43.6% | +1.7 |
| Q4 FY2024 | Dec 31, 2024 | 44.9% | +1.5 |
| Q3 FY2024 | Sep 30, 2024 | 44.6% | +3.6 |
| Q2 FY2024 | Jun 30, 2024 | 44.1% | +3.3 |
| Q1 FY2024 | Mar 31, 2024 | 41.9% | +2.0 |
| Q4 FY2023 | Dec 31, 2023 | 43.5% | +2.5 |
| Q3 FY2023 | Sep 30, 2023 | 41.0% | +3.0 |
| Q2 FY2023 | Jun 30, 2023 | 40.8% | +5.6 |
| Q1 FY2023 | Mar 31, 2023 | 39.9% | +7.3 |
| Q4 FY2022 | Dec 31, 2022 | 41.0% | +5.0 |
| Q3 FY2022 | Sep 30, 2022 | 38.0% | −1.0 |
| Q2 FY2022 | Jun 30, 2022 | 35.1% | −8.4 |
| Q1 FY2022 | Mar 31, 2022 | 32.6% | −3.4 |
| Q4 FY2021 | Dec 31, 2021 | 36.0% | −9.6 |
| Q3 FY2021 | Sep 30, 2021 | 38.9% | −4.2 |
| Q2 FY2021 | Jun 30, 2021 | 43.5% | +11.3 |
| Q1 FY2021 | Mar 31, 2021 | 36.0% | −7.7 |
| Q4 FY2020 | Dec 31, 2020 | 45.6% | −1.1 |
| Q3 FY2020 | Sep 30, 2020 | 43.1% | −5.5 |
| Q2 FY2020 | Jun 30, 2020 | 32.2% | −15.9 |
| Q1 FY2020 | Mar 31, 2020 | 43.7% | −5.6 |
| Q4 FY2019 | Dec 31, 2019 | 46.7% | −1.8 |
| Q3 FY2019 | Sep 30, 2019 | 48.6% | +1.8 |
| Q2 FY2019 | Jun 30, 2019 | 48.1% | +3.1 |
| Q1 FY2019 | Mar 31, 2019 | 49.3% | +6.2 |
| Q4 FY2018 | Dec 31, 2018 | 48.5% | +5.0 |
| Q3 FY2018 | Sep 30, 2018 | 46.8% | +4.7 |
| Q2 FY2018 | Jun 30, 2018 | 45.1% | +1.1 |
| Q1 FY2018 | Mar 31, 2018 | 43.0% | +3.1 |
| Q4 FY2017 | Dec 31, 2017 | 43.6% | −1.5 |
| Q3 FY2017 | Sep 30, 2017 | 42.1% | – |
| Q2 FY2017 | Jun 30, 2017 | 43.9% | – |
| Q1 FY2017 | Mar 31, 2017 | 40.0% | – |
| Q4 FY2016 | Dec 31, 2016 | 45.1% | – |
See a number that looks wrong?